Hans K Hasselbalch

Hans K Hasselbalch

Clinical Professor

Member of:

  • Internal Medicine: Haematology


Publication year:
All
51 - 60 out of 133Page size: 10
  1. 2020
  2. Published

    Ropeginterferon Alfa-2b: Efficacy and Safety in Different Age Groups

    Gisslinger, H., Klade, C., Georgiev, P., Krochmalczyk, D., Gercheva-kyuchukova, L., Egyed, M., Rossiev, V., Dulicek, P., Illes, A., Pylypenko, H., Sivcheva, L., Mayer, J., Yablokova, V., Krejcy, K., Hasselbalch, Hans Carl, Kralovics, R. & Kiladjian, J., 2020, In: HemaSphere. 4, 6, 4 p., e485.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study

    Gisslinger, H., Klade, C., Georgiev, P., Krochmalczyk, D., Gercheva-Kyuchukova, L., Egyed, M., Rossiev, V., Dulicek, P., Illes, A., Pylypenko, H., Sivcheva, L., Mayer, J., Yablokova, V., Krejcy, K., Grohmann-Izay, B., Hasselbalch, H. C., Kralovics, R., Kiladjian, J. J., Bauer, F., Berbec, N. & 41 others, Besses Raebel, C., Borbenyi, Z., Bumbea, H., Buxhofer-Ausch, V., Calbecka, M., Cayssials-Caylus, E., Cazzola, M., Cerna, O., Cucuianu, A., Dima, D. M., Forjan, E., Gheorghita, E., Greil, R., Hatalova, A., Hrubisko, M., Jakucs, J., Kaplan, P., Klymenko, S., Koschmieder, S., Lazaroiu, M., Lysa, T., Masliak, Z., Masszi, T., Mihaylov, G., Myasnikov, A., Platzbecker, U., Puyade, M., Rey, J., Roy, L., Schwarz, J., Skotnicki, A., Sokolova, I., Soroka-Wojtaszko, M., Starzak-Gwozdz, J., Stoeva, V., Torregrosa-Diaz, J. M., Vallova, A., Volodicheva, E., Warzocha, K., Willenbacher, E. & Wolf, D., 2020, In: The Lancet Haematology. 7, 3, p. e196-e208 13 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Safety and efficacy of the combination of sonidegib and ruxolitinib in myelofibrosis: A phase 1b/2 dose-finding study

    Gupta, V., Wolleschak, D., Hasselbalch, Hans Carl, Vannucchi, A. M., Koschmieder, S., Cervantes, F., Li, Y., Dong, T., Wroclawska, M., Bharathy, S. & Harrison, C., 2020, In: Blood advances. 4, 13, p. 3063-3071 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Tocilizumab and soluble interleukin-6 receptor in JAK2V617F somatic mutation and myeloproliferative neoplasm

    Pedersen, K. M., Çolak, Y., Hasselbalch, Hans Carl, Bojesen, Stig Egil & Nordestgaard, Børge, 2020, In: EClinicalMedicine. 22, 100337.

    Research output: Contribution to journal › Comment/debate › Research › peer-review

  6. Published

    Two-fold risk of pneumonia and respiratory mortality in individuals with myeloproliferative neoplasm: A population-based cohort study

    Pedersen, K. M., Çolak, Y., Hasselbalch, Hans Carl, Ellervik, Christina, Nordestgaard, Børge & Bojesen, Stig Egil, 2020, In: EClinicalMedicine. 21, 100295.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. 2019
  8. Published

    Ruxolitinib treatment reduces monocytic superoxide radical formation without affecting hydrogen peroxide formation or systemic oxidative nucleoside damage in myelofibrosis

    Bjørn, M. E., Brimnes, M. K., Gudbrandsdottir, S., Andersen, C. L., Poulsen, Henrik Enghusen, Henriksen, T., Hasselbalch, Hans Carl & Nielsen, Claus Henrik, Oct 2019, In: Leukemia and Lymphoma. 60, 10, p. 2549-2557 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Anxiety and depression in patients with Philadelphia-negative myeloproliferative neoplasms: a nationwide population-based survey in Denmark

    Brochmann, N., Flachs, E. M., Christensen, A. I., Bak, M., Andersen, Christen Bertel L, Juel, K., Hasselbalch, Hans Carl, Zwisler, A. & Rottmann, N., 2019, In: Clinical Epidemiology. 11, p. 23-33

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Association of the blood eosinophil count with end-organ symptoms

    Bjerrum, O. W., Siersma, Volkert Dirk, Hasselbalch, Hans Carl, Lind, B. & Andersen, Christen Bertel L, 2019, In: Annals of Medicine and Surgery. 45, p. 11-18

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. Published

    Bridging blood cancers and inflammation: The reduced Cancitis model

    Ottesen, J. T., Pedersen, R. K., Sajid, Z., Gudmand-hoeyer, J., Bangsgaard, K. O., Skov, V., Kjær, L., Knudsen, T. A., Pallisgaard, N., Hasselbalch, Hans Carl & Andersen, M., 2019, In: Journal of Theoretical Biology. 465, p. 90-108

    Research output: Contribution to journal › Journal article › Research › peer-review

  12. Published

    Cancer immune therapy for myeloid malignancies: present and future

    Holmström, M. O. & Hasselbalch, Hans Carl, 2019, In: Seminars in Immunopathology. 41, 1, p. 97-109

    Research output: Contribution to journal › Review › Research › peer-review

Previous 12 3 4 5 6 7 8 9 ...14 Next

ID: 2849472